Status:
SUSPENDED
Thrombus Aspiration in Heavy Thrombus Burden Acute ST-elevation Myocardial Infarction
Lead Sponsor:
The Young Investigator Group of Cardiovascular Research
Conditions:
Coronary Artery Disease
Percutaneous Coronary Intervention
Eligibility:
All Genders
18-75 years
Phase:
NA
Brief Summary
Recent guidelines for the management of ST-elevation myocardial infarction (STEMI) recommend against the routine use of thrombus aspiration (TA) during primary percutaneous coronary intervention (PPCI...
Detailed Description
Recent guidelines for the management of ST-elevation myocardial infarction (STEMI) recommend against the routine use of thrombus aspiration (TA) during primary percutaneous coronary intervention (PPCI...
Eligibility Criteria
Inclusion
- STEMI patients with heavy thrombus burden as assessed by TIMI score of 0-1 or thrombus burden classification 4-5
Exclusion
- STEMI patients with low thrombus burden (TIMI 2-3 or TB 0-3)
- History of hypersensitivity or allergy to any of the study drugs, as well as known or suspected contraindications to the study drugs.
- Symptomatic hypotension and/or an SBP \< 100 mmHg at the time of randomization.
Key Trial Info
Start Date :
July 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2024
Estimated Enrollment :
124 Patients enrolled
Trial Details
Trial ID
NCT04912570
Start Date
July 1 2022
End Date
December 1 2024
Last Update
July 14 2023
Active Locations (4)
Enter a location and click search to find clinical trials sorted by distance.
1
Andalusia Hospitals
Alexandria, Egypt, 21521
2
International Cardiac Center (ICC)
Alexandria, Egypt, 21524
3
Ain Shams University Hospitals
Cairo, Egypt
4
National Heart Institute
Giza, Egypt